Skip to main content

Table 3 Factors associated with the incidence of HAI (Fine and Gray proportional hazards model for competing events)

From: Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survival

Covariate

sHazard ratio (sHR)—[IC95%]

p

Immunodepression

0.52 [0.28, 0.95]

0.035

HScore

1.00 [0.99, 1.01]

0.104

Etoposide treatment

3.75 [1.05, 6.67]

0.032

SOFA score [0–5]

Reference

SOFA score [6–8]

3.14 [1.24, 7.9]

0.0157

SOFA score [8–12]

1.71 [0.61, 4.74]

0.31

SOFA score [12–21]

2.48 [1.01, 6.12]

0.048